BiotechTube
GeneMed Biotechnologies

GeneMed Biotechnologies

San Francisco, United States· Est.
genemed.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

GeneMed Biotechnologies is an established, privately-held player in the diagnostics and life sciences research tools sector, operating from San Francisco. The company leverages a diversified business model combining product sales with contract services, focusing on tissue-based diagnostics (IHC/ISH), molecular diagnostics (PCR components, multiplex assays), and functional recombinant proteins. Its core strengths lie in reagent manufacturing expertise, a growing digital multiplex platform (IntelliPlex/DigiPlex), and a service-oriented approach for OEM and IVD partners. While not a therapeutic developer, GeneMed occupies a critical niche as an enabler for research and diagnostic assay commercialization.

Diagnostics

Technology Platform

Suite of technologies for tissue-based diagnostics (IHC/ISH reagents), digital multiplex analysis (IntelliPlex™ platform with DigiPlex™ instrument), mammalian-expressed recombinant proteins, and IVD reagent manufacturing expertise.

Opportunities

Growth in the digital multiplex assay market for research and clinical use presents a significant opportunity for the IntelliPlex platform.
The expanding trend of outsourcing IVD reagent manufacturing by diagnostic companies provides a steady demand for its contract services.
Continued demand for high-quality, validated reagents in tissue-based cancer diagnostics supports its core product lines.

Risk Factors

Intense competition from large, established life science tools companies and niche players in every segment it operates.
Commercial success of the newer IntelliPlex platform is not assured and requires significant market adoption against competing technologies.
Dependence on the regulatory and commercial success of its OEM and contract manufacturing clients introduces downstream risk.

Competitive Landscape

GeneMed competes in fragmented but crowded markets. In research antibodies and proteins, it faces giants like Abcam, Thermo Fisher, and R&D Systems. In diagnostic reagents and staining systems, competitors include Agilent, Roche, and Leica Biosystems. In multiplex analysis, it competes with Luminex, Qiagen, and newer sequencing-based platforms. Its differentiation lies in its specialized manufacturing expertise, focus on diagnostic optimization, and integrated service offerings.

More companies in Biologics / Biosimilars →More companies in United States →